This study explores why drugs designed to fight off malaria stop working in some people with the disease. Researchers found genetic and cell biological evidence linking autophagy to resistance to the ...
Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs ...
Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...
Although malaria continues to affect 40% of the world's population and is estimated to be responsible for up to 1 million deaths per year, the number of cases reported by the World Health Organization ...
Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...
Most people with lupus take an antimalarial drug to control their symptoms. These drugs may also prevent blood clots and damage to your organs from lupus. Antimalarials are mostly safe to use and ...
A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including ...
Malaria parasites may build up a genetic tolerance to an antimalarial drug, but they can’t spread that resistance to future generations, researchers report in the April 15 Science. Malaria parasites ...
Army researchers developed mefloquine during the Vietnam War. Roche, a Swiss drugmaker, was granted the intellectual property ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results